OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics Corp KIDS.OQ KIDS.O is expected to show a rise in quarterly revenue when it reports results on August 4 for the period ending June 30 2026
The Warsaw Indiana Indiana-based company is expected to report a 11.7% increase in revenue to $68.247 million from $61.08 million a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
LSEG's mean analyst estimate for OrthoPediatrics Corp is for a loss of 30 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OrthoPediatrics Corp is $24.00, about 19.3% above its last closing price of $20.11
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.46 | -0.47 | -0.45 | Beat | 4.9 |
Dec. 31 2026 | -0.33 | -0.34 | -0.43 | Missed | -27.9 |
Sep. 30 2025 | -0.24 | -0.26 | -0.50 | Missed | -93.4 |
Jun. 30 2025 | -0.32 | -0.30 | -0.30 | Met | 0.9 |
Mar. 31 2025 | -0.45 | -0.45 | -0.46 | Missed | -2.1 |
Dec. 31 2024 | -0.33 | -0.31 | -0.69 | Missed | -120.2 |
Sep. 30 2024 | -0.22 | -0.24 | -0.34 | Missed | -41.1 |
Jun. 30 2024 | -0.26 | -0.27 | -0.26 | Beat | 5.1 |
This summary was machine generated July 31 at 20:16 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Orthopediatrics
See all newsOrthoPediatrics Corp reports results for the quarter ended June 30 - Earnings Summary
OrthoPediatrics Q2 revenue rises 15%, beats estimates
Brief: OrthoPediatrics Q2 EPS USD -0.3
OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics beats Q1 revenue estimates, raises 2026 outlook